The AR3T Pilot Funding Program supports researchers in the development of innovative, interdisciplinary Regenerative Rehabilitation research projects.
Overview: Stem cells interpret mechanical forces in a broad spectrum of ways that can affect their behavior and, ultimately, their ability to drive tissue regeneration. AR3T is looking to support researchers who propose interdisciplinary approaches combining regenerative medicine with mechanical stimulation, with the aim of optimizing outcomes.
The Regenerative Rehabilitation research community is benefiting from the development of novel lines of research that incorporate methods utilizing electrical or mechanical stimulation of stem cells, applied biophysics and/or tissue engineering approaches, and assessing stem cell behavior and/or functional outcomes.
A proposed project must include both a regenerative medicine/stem cell biology component as well as a rehabilitative/mechanotransductive component. Contact email@example.com if you would be interested in forming a collaboration with an AR3T researcher on a proposal.
Eligible Individuals: The AR3T pilot funding program is open to junior investigators and mid-level career faculty. The Principal Investigator (PI) should have a doctoral degree in a relevant field and be employed at an nonprofit institution within the United States. The goal is to fund researchers who are interested in beginning a career in Regenerative Rehabilitation research or who would like to start a new line of research in this area.
Examples of funded pilot projects include:
- Michael Modo (University of Pittsburgh): Neuro-biological effects of rehabilitation on neural stem cell transplantation after stroke
- Sarah Heilshorn (Stanford): Protein-engineered nerve guidance conduits for peripheral nerve injury recovery and rehabilitation
- Jarrod Call (UGA) and Sarah Greising (USAISR): Protein-engineered nerve guidance conduits for peripheral nerve injury recovery and rehabilitation
- Joseph Roche (Wayne State): Novel rehabilitative interventions for muscle loss
- Ngan Huang (PAVIR): Nano-aligned scaffold conjugated with insulin-like growth factor-1 mRNA for treatment of volumetric muscle loss
- Riccardo Gottardi (University of Pittsburgh): R-CaRe-Rehabilitation for cartilage regeneration
- David Mack (University of Washington): Electromechanical maturation of iPSC-derived myotubes in vitro